Upcoming Conferences in the Life Sciences Industry
Biotechgate Digital Partnering November 2023
Representatives from Venture Valuation and Biotechgate will participate in Biotechgate Digital Partnering November 2023.
Pharma-Biotech Product & Company Valuation with Dr. P Frei
Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world – Know how to assess and calculate the value of a biotech company – Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal.
Representatives from Venture Valuation and Biotechgate will participate in Pharma-Biotech Product & Company Valuation with Dr. P Frei.
Dutch Life Sciences Conference
The annual Genesis conference has been a pillar of the Life Science sector for over two decades. Bringing together key opinion leaders, investors and innovators from across the sector to share insight, debate key trends and generate deals.
We expect 2023 to be no different! Under a headline theme of Maximising Returns from Life Science Innovation the event will feature:
High content mix of keynote talks and panel discussions from key opinion leaders.
Networking with 300 delegates on the day.
Option to arrange 1 to 1 meetings with delegates via the event app.
Genesis Fringe events for informal in-person networking.
Digital Innovation Workshops in the lead-up to the in-person Genesis conference for technical and business insights.
Exhibition for invaluable innovation support from our network.
Delegate rates from only £325 +VAT.
Sponsorship opportunities from £5K + VAT.
Exhibitor opportunities from £500 + VAT.
Remaining in the prestigious and easily accessible 1 Wimpole Street venue in Central London, fittingly the home of the Royal Society of Medicine, Genesis 2023 is set to deliver a fantastic opportunity for the ecosystem to connect, collaborate and create return for innovators, investors, patients and society.
Follow us on Twitter @OneNucleus using #GenesisLondon23.
You can find a list of companies that attended Genesis 2022 here: https://www.genesisconference.com/attending-companies
BioFIT takes place on-site December 12-13, with online partnering on December 15.
7th Annual Neuroscience Innovation Forum
The forum, positioned at the beginning of JPM week, focuses on the latest developments across key areas of Neuroscience which are currently drawing widespread investor interest. The main programme for the 7th Annual NIF will feature more than 8 hours of high-level keynotes and panel discussions addressing the important advances in therapeutic, neurotech and diagnostics fields.
Representatives from Venture Valuation and Biotechgate will participate in 7th Annual Neuroscience Innovation Forum.
Representatives from Venture Valuation and Biotechgate will participate in Biotech Showcase™.
J.P. Morgan 42nd Annual Healthcare Conference
This premier conference is the largest and most informative health care investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community.
Representatives from Venture Valuation and Biotechgate will participate in J.P. Morgan 42nd Annual Healthcare Conference.
Redefining Early Stage Investments (RESI)
Representatives from Venture Valuation and Biotechgate will participate in Redefining Early Stage Investments (RESI).
Biotechgate Digital Partnering February 2024
Representatives from Venture Valuation and Biotechgate will participate in Biotechgate Digital Partnering February 2024.
BIO CEO & Investor Conference
Don't miss your opportunity to:
Find and request meetings with potential partners using the BIO One-on-One Partnering™ system
Discover the latest innovations in biotech during Company Presentations
Hear from thought-leaders during sessions on therapeutic advancements, market outlook, and policy priorities
Representatives from Venture Valuation and Biotechgate will participate in BIO CEO & Investor Conference.
17th Annual European Life Sciences CEO Forum
The success and longevity of the forum is built on the goodwill and repeat attendance of major corporate and financial investors, and pharma licensing executives and advisors, who are seeking to network with biotechs. The programme and presentations allow all to keep up with the latest industry developments and strategize for 2024. The physical programme will consist of the usual panels and keynotes, which will be available on demand from the 6th of March. Additionally, there will be pre-arranged in-person meetings, live and on demand company showcases and a reception. During the online week, virtual meetings will be available through the audio/video online meeting system.
The main programme for the 17th Annual ELSF is spread throughout 2 days (28th - 29th of February) and will feature more than 12 hours of high-level keynotes and panel discussions. In addition, there will be a global company showcase of 50+ presentations by established public, private, emerging and seed companies, offering innovative solutions and seeking investment and partnering opportunities. This will include a limited number of live presentations taking place in dedicated presentation tracks, alongside virtual company showcases, which will be available on demand during the virtual week. We anticipate 400+ delegates will register for the forum from all Life Sciences sectors, with the target audience being corporate and financial investors/partners, banks and advisors with part of the audience participating virtually.
Representatives from Venture Valuation and Biotechgate will participate in 17th Annual European Life Sciences CEO Forum.
BIO-Europe Spring® 2024
Building and nurturing relationships is an essential part of the progression of successful business partnerships. BIO-Europe Spring 2024 will offer a fusion of innovative digital solutions and a vibrant on-site event of unprecedented scope.
Expanding on the success of EBD Group’s flagship conference, BIO-Europe® , BIO-Europe Spring will bring together over 3,700 leading executives from around the world. Specifically, we will host more than 20,000 partnering meetings to connect leaders from academia, start-up, and scale-up biotech companies with forward-thinking investors and pharma companies. Along with world-class workshops and panels, innovative company presentations, active exhibition and a variety of networking opportunities make this event an unrivalled forum for companies across the biotech value chain to meet and do business.
Representatives from Venture Valuation and Biotechgate will participate in BIO-Europe Spring® 2024.
Pharma-Biotech Product & Company Valuation - An Introductory
The different valuation methods used for life science companies and products.
How to calculate the value of a biotech or life science company with the Discounted Cash Flow method, comparables and exit valuation.
How to use risk-adjusted Net Present Value (rNPV) to calculate the value of a pharmaceutical compound in development.
How to structure the licensing deal between companies, covering issues such as milestone and royalty payments.
Representatives from Venture Valuation and Biotechgate will participate in Pharma-Biotech Product & Company Valuation - An Introductory.
Swiss Biotech Day 2024
Representatives from Venture Valuation and Biotechgate will participate in Swiss Biotech Day 2024.